Effectiveness of first- or second-line bevacizumab (BV) treatment (tx) in elderly patients (pts) with metastatic colorectal cancer (mCRC) in ARIES, an observational cohort study (OCS).
M. Kozloff
Consultant or Advisory Role - Genentech
Honoraria - Genentech
T. S. Bekaii-Saab
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech
Honoraria - Amgen; Bristol-Myers Squibb; Genentech; Onyx
Research Funding - Pfizer
J. C. Bendell
Research Funding - Genentech
A. L. Cohn
No relevant relationships to disclose
H. Hurwitz
Consultant or Advisory Role - Genentech
Honoraria - Roche
Research Funding - Genentech
N. Roach
Consultant or Advisory Role - Genentech
Research Funding - Genentech
H. Tezcan
No relevant relationships to disclose
S. Fish
Employment or Leadership Position - Genentech
Stock Ownership - Roche
E. D. Flick
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Y. Mun
Employment or Leadership Position - Genentech
Stock Ownership - Roche
D. Dalal
Employment or Leadership Position - Genentech
Stock Ownership - Roche
A. Grothey
Consultant or Advisory Role - Amgen; Bayer; Genentech; ImClone Systems
Research Funding - Bayer; Daiichi Sankyo; Genentech